MKI67 and neoplasm: Ab417 treatment resulted in 30% tumor growth inhibition compared to the control, based on mean tumor volume (data not shown), and the Ab417-treated tumors showed a lower Ki-67 index compared to the control tumors, indicating that Ab417 inhibits tumor growth by inhibiting tumor cell proliferation in vivo (Fig 1D and S1 Fig).